Annual SG&A
$15.54 M
+$1.11 M+7.68%
31 December 2023
Summary:
Aptose Biosciences annual selling, general & administrative expenses is currently $15.54 million, with the most recent change of +$1.11 million (+7.68%) on 31 December 2023. During the last 3 years, it has fallen by -$10.80 million (-41.01%). APTO annual SG&A is now -41.01% below its all-time high of $26.34 million, reached on 31 December 2020.APTO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.26 M
-$668.00 K-22.82%
30 September 2024
Summary:
Aptose Biosciences quarterly selling, general & administrative expenses is currently $2.26 million, with the most recent change of -$668.00 thousand (-22.82%) on 30 September 2024. Over the past year, it has dropped by -$1.16 million (-33.85%). APTO quarterly SG&A is now -74.85% below its all-time high of $8.98 million, reached on 30 June 2020.APTO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.11 B
-$35.80 M-1.72%
30 September 2024
Summary:
Aptose Biosciences TTM selling, general & administrative expenses is currently -$2.11 billion, with the most recent change of -$35.80 million (-1.72%) on 30 September 2024. Over the past year, it has dropped by -$2.13 billion (-13181.46%). APTO TTM SG&A is now -9948.97% below its all-time high of $28.47 million, reached on 31 March 2021.APTO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APTO Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.7% | -33.9% | -10000.0% |
| 3 y3 years | -41.0% | -37.4% | -10000.0% |
| 5 y5 years | +50.6% | +0.4% | -10000.0% |
APTO Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -41.0% | +7.7% | -57.1% | at low | -39.4% | at low |
| 5 y | 5 years | -41.0% | +57.0% | -74.8% | +0.4% | -85.6% | at low |
| alltime | all time | -41.0% | +1328.0% | -74.8% | +1025.6% | -9949.0% | at low |
Aptose Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.26 M(-22.8%) | $11.50 M(-9.1%) |
| June 2024 | - | $2.93 M(-11.5%) | $12.65 M(-6.9%) |
| Mar 2024 | - | $3.31 M(+10.2%) | $13.59 M(-12.6%) |
| Dec 2023 | $15.54 M(+7.7%) | $3.00 M(-12.1%) | $15.54 M(-3.8%) |
| Sept 2023 | - | $3.42 M(-11.5%) | $16.15 M(-0.1%) |
| June 2023 | - | $3.86 M(-26.8%) | $16.16 M(+3.5%) |
| Mar 2023 | - | $5.27 M(+45.9%) | $15.61 M(+8.2%) |
| Dec 2022 | $14.43 M(-25.3%) | $3.61 M(+5.4%) | $14.43 M(-3.3%) |
| Sept 2022 | - | $3.42 M(+3.4%) | $14.93 M(-1.2%) |
| June 2022 | - | $3.31 M(-19.0%) | $15.11 M(-2.0%) |
| Mar 2022 | - | $4.09 M(-0.4%) | $15.42 M(-20.2%) |
| Dec 2021 | $19.32 M(-26.7%) | $4.11 M(+13.9%) | $19.32 M(-7.9%) |
| Sept 2021 | - | $3.61 M(-0.4%) | $20.97 M(-9.2%) |
| June 2021 | - | $3.62 M(-54.7%) | $23.11 M(-18.8%) |
| Mar 2021 | - | $7.99 M(+38.8%) | $28.47 M(+8.1%) |
| Dec 2020 | $26.34 M(+166.1%) | $5.75 M(+0.2%) | $26.34 M(+13.6%) |
| Sept 2020 | - | $5.74 M(-36.1%) | $23.19 M(+17.7%) |
| June 2020 | - | $8.98 M(+53.1%) | $19.70 M(+45.6%) |
| Mar 2020 | - | $5.87 M(+125.6%) | $13.53 M(+36.6%) |
| Dec 2019 | $9.90 M(-4.1%) | $2.60 M(+15.6%) | $9.90 M(+5.0%) |
| Sept 2019 | - | $2.25 M(-19.9%) | $9.43 M(+2.7%) |
| June 2019 | - | $2.81 M(+25.4%) | $9.18 M(+3.5%) |
| Mar 2019 | - | $2.24 M(+5.4%) | $8.87 M(-14.1%) |
| Dec 2018 | $10.32 M(+87.6%) | $2.13 M(+6.3%) | $10.32 M(+9.4%) |
| Sept 2018 | - | $2.00 M(-20.0%) | $9.44 M(+7.9%) |
| June 2018 | - | $2.50 M(-32.3%) | $8.74 M(+14.7%) |
| Mar 2018 | - | $3.69 M(+198.0%) | $7.62 M(+38.5%) |
| Dec 2017 | $5.50 M(-13.5%) | $1.24 M(-5.1%) | $5.50 M(+1.3%) |
| Sept 2017 | - | $1.31 M(-5.2%) | $5.43 M(-2.6%) |
| June 2017 | - | $1.38 M(-12.5%) | $5.58 M(-6.9%) |
| Mar 2017 | - | $1.58 M(+34.5%) | $6.00 M(-6.5%) |
| Dec 2016 | $6.36 M(-19.9%) | $1.17 M(-19.4%) | $6.41 M(-16.1%) |
| Sept 2016 | - | $1.45 M(-19.0%) | $7.64 M(-2.6%) |
| June 2016 | - | $1.79 M(-9.9%) | $7.85 M(-2.6%) |
| Mar 2016 | - | $1.99 M(-17.0%) | $8.06 M(-2.3%) |
| Dec 2015 | $7.94 M(+66.9%) | $2.40 M(+44.6%) | $8.24 M(+41.1%) |
| Sept 2015 | - | $1.66 M(-17.1%) | $5.84 M(+39.7%) |
| June 2015 | - | $2.00 M(-8.1%) | $4.18 M(-5.3%) |
| Mar 2015 | - | $2.18 M(-2.6%) | $4.41 M(-27.4%) |
| Dec 2014 | $4.76 M(-21.2%) | - | - |
| May 2014 | $6.04 M(+174.4%) | $2.24 M(+40.5%) | $6.08 M(+42.2%) |
| Feb 2014 | - | $1.59 M(-12.9%) | $4.28 M(+35.1%) |
| Nov 2013 | - | $1.83 M(+326.7%) | $3.16 M(+53.9%) |
| Aug 2013 | - | $427.80 K(-1.1%) | $2.06 M(-8.0%) |
| May 2013 | $2.20 M(-6.3%) | $432.50 K(-9.6%) | $2.24 M(-3.8%) |
| Feb 2013 | - | $478.60 K(-33.3%) | $2.32 M(-0.0%) |
| Nov 2012 | - | $717.80 K(+18.2%) | $2.32 M(-2.7%) |
| Aug 2012 | - | $607.20 K(+16.8%) | $2.39 M(+1.7%) |
| May 2012 | $2.35 M(-4.6%) | $519.90 K(+8.6%) | $2.35 M(-1.5%) |
| Feb 2012 | - | $478.80 K(-38.9%) | $2.39 M(-8.9%) |
| Nov 2011 | - | $783.50 K(+37.9%) | $2.62 M(+9.7%) |
| Aug 2011 | - | $568.00 K(+2.1%) | $2.39 M(-0.5%) |
| May 2011 | $2.46 M | $556.10 K(-21.9%) | $2.40 M(-20.3%) |
| Feb 2011 | - | $711.70 K(+28.9%) | $3.01 M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2010 | - | $552.20 K(-4.6%) | $2.88 M(-2.2%) |
| Aug 2010 | - | $579.00 K(-50.4%) | $2.94 M(-0.1%) |
| May 2010 | $2.98 M(-4.7%) | $1.17 M(+101.5%) | $2.95 M(+8.9%) |
| Feb 2010 | - | $579.40 K(-6.3%) | $2.71 M(-4.2%) |
| Nov 2009 | - | $618.30 K(+6.1%) | $2.82 M(-6.7%) |
| Aug 2009 | - | $582.50 K(-37.1%) | $3.03 M(-7.6%) |
| May 2009 | $3.12 M(-30.0%) | $926.10 K(+32.7%) | $3.28 M(-6.7%) |
| Feb 2009 | - | $697.90 K(-14.9%) | $3.51 M(-10.3%) |
| Nov 2008 | - | $819.70 K(-1.6%) | $3.92 M(-11.1%) |
| Aug 2008 | - | $833.10 K(-28.4%) | $4.41 M(+0.9%) |
| May 2008 | $4.46 M(+9.6%) | $1.16 M(+5.5%) | $4.37 M(-0.1%) |
| Feb 2008 | - | $1.10 M(-15.9%) | $4.37 M(+7.4%) |
| Nov 2007 | - | $1.31 M(+65.1%) | $4.07 M(-1.3%) |
| Aug 2007 | - | $794.00 K(-31.9%) | $4.13 M(-0.5%) |
| May 2007 | $4.07 M(-19.1%) | $1.17 M(+45.5%) | $4.15 M(+7.1%) |
| Feb 2007 | - | $801.90 K(-41.2%) | $3.87 M(-8.2%) |
| Nov 2006 | - | $1.36 M(+67.2%) | $4.22 M(-8.2%) |
| Aug 2006 | - | $815.40 K(-8.7%) | $4.60 M(-6.8%) |
| May 2006 | $5.03 M(-7.5%) | $893.00 K(-22.4%) | $4.94 M(-8.5%) |
| Feb 2006 | - | $1.15 M(-33.9%) | $5.39 M(-5.8%) |
| Nov 2005 | - | $1.74 M(+51.2%) | $5.72 M(+1.3%) |
| Aug 2005 | - | $1.15 M(-14.7%) | $5.65 M(+3.9%) |
| May 2005 | $5.44 M(+50.7%) | $1.35 M(-8.7%) | $5.44 M(+5.9%) |
| Feb 2005 | - | $1.48 M(-11.4%) | $5.14 M(+16.4%) |
| Nov 2004 | - | $1.67 M(+77.4%) | $4.41 M(+20.9%) |
| Aug 2004 | - | $941.30 K(-10.0%) | $3.65 M(+1.4%) |
| May 2004 | $3.61 M(-0.3%) | $1.05 M(+38.3%) | $3.60 M(-12.4%) |
| Feb 2004 | - | $756.60 K(-16.5%) | $4.11 M(+2.8%) |
| Nov 2003 | - | $906.30 K(+1.9%) | $4.00 M(+11.0%) |
| Aug 2003 | - | $889.30 K(-42.8%) | $3.60 M(+1.5%) |
| May 2003 | $3.62 M(+13.6%) | $1.55 M(+140.5%) | $3.55 M(+27.9%) |
| Feb 2003 | - | $646.60 K(+27.1%) | $2.77 M(-3.8%) |
| Nov 2002 | - | $508.90 K(-39.2%) | $2.88 M(-14.7%) |
| Aug 2002 | - | $837.20 K(+7.3%) | $3.38 M(+4.7%) |
| May 2002 | $3.18 M(-23.7%) | $780.50 K(+3.4%) | $3.23 M(-18.6%) |
| Feb 2002 | - | $754.80 K(-25.0%) | $3.96 M(-5.5%) |
| Nov 2001 | - | $1.01 M(+46.9%) | $4.20 M(+3.2%) |
| Aug 2001 | - | $685.00 K(-54.9%) | $4.07 M(-3.4%) |
| May 2001 | $4.17 M(+71.2%) | $1.52 M(+54.0%) | $4.21 M(+2.8%) |
| Feb 2001 | - | $986.00 K(+12.5%) | $4.09 M(+5.9%) |
| Nov 2000 | - | $876.10 K(+5.9%) | $3.86 M(+16.1%) |
| Aug 2000 | - | $827.00 K(-41.1%) | $3.33 M(+23.2%) |
| May 2000 | $2.44 M(+111.4%) | $1.40 M(+85.1%) | $2.70 M(+70.0%) |
| Feb 2000 | - | $758.10 K(+123.3%) | $1.59 M(+29.3%) |
| Nov 1999 | - | $339.50 K(+69.2%) | $1.23 M(+6.9%) |
| Aug 1999 | - | $200.70 K(-31.1%) | $1.15 M(-4.4%) |
| May 1999 | $1.15 M(-11.6%) | $291.20 K(-26.8%) | $1.20 M(-12.4%) |
| Feb 1999 | - | $397.70 K(+52.7%) | $1.37 M(+9.3%) |
| Nov 1998 | - | $260.40 K(+2.9%) | $1.26 M(-1.6%) |
| Aug 1998 | - | $253.10 K(-45.1%) | $1.28 M(-2.7%) |
| May 1998 | $1.30 M(+19.8%) | $461.20 K(+64.1%) | $1.31 M(+54.2%) |
| Feb 1998 | - | $281.10 K(0.0%) | $850.20 K(+49.4%) |
| Nov 1997 | - | $281.10 K(-2.4%) | $569.10 K(+97.6%) |
| Aug 1997 | - | $288.00 K | $288.00 K |
| May 1997 | $1.09 M | - | - |
FAQ
- What is Aptose Biosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Aptose Biosciences?
- What is Aptose Biosciences annual SG&A year-on-year change?
- What is Aptose Biosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Aptose Biosciences?
- What is Aptose Biosciences quarterly SG&A year-on-year change?
- What is Aptose Biosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Aptose Biosciences?
- What is Aptose Biosciences TTM SG&A year-on-year change?
What is Aptose Biosciences annual selling, general & administrative expenses?
The current annual SG&A of APTO is $15.54 M
What is the all time high annual SG&A for Aptose Biosciences?
Aptose Biosciences all-time high annual selling, general & administrative expenses is $26.34 M
What is Aptose Biosciences annual SG&A year-on-year change?
Over the past year, APTO annual selling, general & administrative expenses has changed by +$1.11 M (+7.68%)
What is Aptose Biosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of APTO is $2.26 M
What is the all time high quarterly SG&A for Aptose Biosciences?
Aptose Biosciences all-time high quarterly selling, general & administrative expenses is $8.98 M
What is Aptose Biosciences quarterly SG&A year-on-year change?
Over the past year, APTO quarterly selling, general & administrative expenses has changed by -$1.16 M (-33.85%)
What is Aptose Biosciences TTM selling, general & administrative expenses?
The current TTM SG&A of APTO is -$2.11 B
What is the all time high TTM SG&A for Aptose Biosciences?
Aptose Biosciences all-time high TTM selling, general & administrative expenses is $28.47 M
What is Aptose Biosciences TTM SG&A year-on-year change?
Over the past year, APTO TTM selling, general & administrative expenses has changed by -$2.13 B (-13181.46%)